Dr. Essam Hamza reports

TREATMENT.COM AI ANNOUNCES NON-BROKERED PRIVATE PLACEMENT OF UP TO $1,750,000 OF SPECIAL WARRANTS

Treatment.com AI Inc. is undertaking a non-brokered private placement of up to 2,333,333 special warrants of the company at a price of 75 cents per special warrant, for aggregate gross proceeds of up to $1.75-million.

Each special warrant will automatically convert into one unit of the company. Each unit shall consist of one common share of the company and one-half of one common share purchase warrant. Each warrant shall entitle the holder thereof to acquire one share at a price of $1.00 per share for a period of 24 months following the date of issuance of the warrants.

Each special warrant will automatically convert, for no additional consideration, into units on the date (the conversion date) that is the earlier of: (i) the third business day after the date of filing a prospectus supplement to a short form base shelf prospectus qualifying the distribution of the shares and warrants issuable upon the conversion of the special warrants, and (ii) four months and one day after the issue date of the special warrants. No special warrants may be exercised by the holder thereof prior to the conversion date.

The company will use its commercially reasonable efforts to file the prospectus supplement to qualify the distribution of the shares and warrants issuable upon conversion of the special warrants within 60 days of the closing of the offering (not including the date of closing).

The company may pay a finder's fee of up to 8 per cent of the gross proceeds of the offering and may issue to certain eligible finders non-transferable broker warrants equal up to 8 per cent of the number of special warrants sold under the offering. Each broker warrant will entitle the holder to purchase one share at an exercise price of $1.00 per broker share for a period of 24 months from the date of issuance of the broker warrants.

The company intends to use the proceeds raised from the offering for working capital purposes. The offering is expected to close on or before Oct. 11, 2024. The offering is subject to certain conditions including, but not limited to, receipt of all necessary approvals including the approval of the Canadian Securities Exchange. Prior to the filing of the prospectus supplement and the automatic conversion of the special warrants, all securities issued in connection with the offering will be subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation. The offering is not subject to a minimum aggregate amount of subscriptions.

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI and best clinical practices to positively improve the health care sector and impact current inefficiencies and challenges. With the input of hundreds of health care professionals globally, Treatment.com has built a comprehensive, personalized health care AI engine, the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all health care professionals as well as providing recommended tests (physical and lab), X-rays and billing codes. The GLM helps health care professionals (doctor, nurse or pharmacist) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. Treatment.com's GLM platform, through supporting health care professionals, allows for the inclusion for disenfranchised communities.

We seek Safe Harbor.